Table 1.
Source | Country of origin |
No. of Patients |
Mean Age (years) |
Male (%) |
Center | Mean APACHE II/III/ SAPS II/ SOFA score |
Diagnosis | Jadad Score* |
---|---|---|---|---|---|---|---|---|
Huang, 2010(23) | China | 44 | 74.9 | 45.5 | S | APACHE II: 28.8 SOFA: 7.6 | Severe sepsis or septic shock† | 2 |
Peng, 2010(9) | China | 22 | 53.4 | 59.1 | S | APACHE II:18.6 | Severe sepsis† | 2 |
Cruz, 2009(24) | Italy | 64 | 64 | 65.5 | M | APACHE II: 20.5 SOFA: 10 | Severe sepsis or septic shock† | 5 |
Payen, 2009(25) | France | 76 | 58.1 | 74.4 | M | SAPS II: 53.4 SOFA:11 | Severe sepsis or septic shock† | 2 |
Peng, 2005(26) | China | 20 | 33.2 | 95 | S | N/A | Sepsis† | 1 |
Vincent, 2005(27) | Belgium | 35 | 57.5 | 63 | M | APACHE II: 17.7 SOFA:10.1 | Severe sepsis or septic shock† | 4 |
Reinhart, 2004(28) | Germany | 143 | 61.2 | 62.2 | M | APACHE II:28 SOFA:11.8 | Severe sepsis or septic shock† | 4 |
Nakamura, 2004(29) | Japan | 25 | 60 | 75 | S | APACHE II:28.2 | Severe sepsis† | 3 |
Nakamura, 2003(30) | Japan | 20 | 63.7 | 60 | S | APACHE II:27.3 | Sepsis† | 2 |
Nakamura, 2003(31) | Japan | 60 | 55.5 | 66.7 | S | APACHE II:23.5 | Sepsis† | 4 |
Busund, 2002(32) | Norway | 106 | 44 | 56.6 | S | APACHE III: 54.9 | Severe sepsis or septic shock† | 2 |
Nakamura, 2002(33) | Japan | 18 | 40 | 66.7 | S | APACHE II: 28 | Sepsis† | 3 |
Cole, 2002(17) | Australia | 24 | 66.8 | 58.3 | S | APACHE II: 22 SAPS II: 45 | Septic shock or septic organ dysfunction† | 5 |
Nemoto, 2001(34) | Japan | 98 | 62 | 61.2 | S | APACHE II: 22.5 | Sepsis, severe sepsis or septic shock† | 2 |
Reeves, 1999(35) | Australia | 22 | 59.4 | 63.6 | M | APACHE II: 25.2 | Sepsis†† | 2 |
Nakamura, 1999(36) | Japan | 50 | 53.8 | 60 | M | APACHE II: 24.8 | Septic shock†† | 1 |
APACHE, acute physiology and chronic health evaluation; SAPS, simplified acute physiology score; SOFA, sequential organ failure assessment; S, single center trial; M, multicenter trial; N/A, not applicable.
Jadad score was calculated using investigator-blinding in place of double-blind design.
Patients were diagnosed according to the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria;
Patients were diagnosed according to the other criteria.